Related Experiment Video
Updated: May 10, 2026

Quantifying the Level of 8-oxo-dG Using ELISA Assay to Evaluate Oxidative DNA Damage in MCF-7 Cells
Published on: May 24, 2024
DNA damage induced by oridonin involves cell cycle arrest at G2/M phase in human MCF-7 cells
1Central Research Laboratory, the First Affiliated Hospital of Jilin University, Changchun, China ; School of Basic Medical Sciences, Jiamusi University, No. 148 Xuefu Street, Jiamusi City, Heilongjiang Province, China.
Aim Of The Study:
To study the mechanisms of inhibition of cell growth and induction of DNA damage in oridonin-treated MCF-7 human breast cancer cells.
Material And Methods:
The cytotoxicity of oridonin-treated MCF-7 cells was measured by MTT assay. Cell cycle phase distribution was analyzed by flow cytometry. P-ATM, P-CHK2, γH2AX and P-P53 protein expressions were detected by Western blot analysis. The expression of r-h2ax and P-ATM was also detected by immunofluorescence staining. The degree of cellular damage of oridonin-induced MCF-7 human breast cancer cells was confirmed by the comet assay analysis of DNA fragmentation.
Results:
Oridonin inhibited cell growth in a time- and dose-dependent manner. The IC50 values at 48 and 72 hours were 78.3 and 31.62 µmol/l, respectively. Oridonin induced G2/M phase arrest in MCF-7 cells. MCF-7 cells treated with oridonin showed significant DNA damage as shown by an increase in olive tail moment (OTM). The protein expression levels of P-ATM, P-CHK2, γH2AX and P-P53 were increased significantly in a dose-dependent manner.
Conclusions:
DNA damage provokes p53-mediated G2/M cell cycle arrest in oridonin-induced MCF-7 cells through the mechanism of CHK2 activation by activated ATM protein kinase, which is induced by oridonin.
Insights
Oridonin inhibits breast cancer cell growth and causes DNA damage, leading to cell cycle arrest. This occurs via ATM/CHK2 activation and subsequent p53 signaling, highlighting oridonin
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Background:
- Oridonin is a natural compound with potential anti-cancer properties.
- Understanding the mechanisms of oridonin's action is crucial for its therapeutic development.
- MCF-7 cells are a commonly used model for human breast cancer research.
Purpose of the Study:
- To investigate how oridonin inhibits cell growth in MCF-7 breast cancer cells.
- To elucidate the mechanisms by which oridonin induces DNA damage.
- To explore the role of key proteins in the DNA damage response pathway.
Main Methods:
- Cytotoxicity was assessed using MTT assays.
- Cell cycle distribution was analyzed via flow cytometry.
- Protein expression (P-ATM, P-CHK2, γH2AX, P-P53) was determined by Western blot and immunofluorescence.
- DNA fragmentation was evaluated using the comet assay.
Main Results:
- Oridonin demonstrated dose- and time-dependent inhibition of MCF-7 cell growth.
- Oridonin induced G2/M phase cell cycle arrest and significant DNA damage.
- Increased expression of P-ATM, P-CHK2, γH2AX, and P-P53 proteins was observed.
Conclusions:
- Oridonin-induced DNA damage triggers a p53-mediated G2/M cell cycle arrest in MCF-7 cells.
- The mechanism involves CHK2 activation by ATM protein kinase, initiated by oridonin.
- These findings provide insight into oridonin's anti-cancer effects.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Overview of DNA Repair
Chemically...
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Inhibition of Cdk Activity

